MedTrace Logo

Optimizing Self-Monitoring Feedback for the Treatment of Obesity

NCT06508580 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2025-04-08

No results posted yet for this study

Summary

Self-monitoring (of weight, intake, and activity) is a core component in evidence-based lifestyle interventions for obesity. Research has shown that interventionist feedback increases adherence to self-monitoring and improves weight loss outcomes; however, little empirical evidence exists on how this feedback should be provided. This research study aims to optimize the provision of self-monitoring feedback.

Conditions

Interventions

BEHAVIORAL

Component 1: Calorie Goal Attainment

On weeks that participants are randomized to receive this component, they will be provided with feedback on the number of days that they met their calorie goal.

BEHAVIORAL

Component 2: Diet Quality

On weeks that participants are randomized to receive this component, they will receive three comments regarding specific dietary choices that may impact weight loss success, including reinforcing comments for behaviors consistent with weight loss and potential areas for change.

BEHAVIORAL

Component 3: Physical Activity Goal Attainment

On weeks that participants are randomized to receive this component, they will receive feedback related to attainment of that week's physical activity goal.

BEHAVIORAL

Component 4: Goal Setting

On weeks that participants are randomized to receive the goal setting component, they will be asked to complete an open-text prompt encouraging them to set a specific weight-related behavior change goal for the next week.

Sponsors & Collaborators

  • University of Florida

    lead OTHER

Principal Investigators

  • Kathryn M Ross, PhD, MPH · University of Florida

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-07-23
Primary Completion
2025-02-03
Completion
2025-02-03

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06508580 on ClinicalTrials.gov